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Abstract 
Background 
 
Veno-arterial extracorporeal membrane oxygenation therapy (VA ECMO) is used 
for short-term circulatory support in the setting of cardiogenic shock or cardiac 
arrest. While VA-ECMO improves hemodynamics and gas exchange, it may 
result in left ventricular distention and pulmonary congestion. 
 
Methods 
The records of all patients supported with VA ECMO for at least three 
consecutive days at our institution from 2012-2014 were retrospectively 
analyzed. All chest radiographs taken during VA ECMO support were graded on 
a scale of 1 to 4. A score of 1 was used when no pulmonary congestion was 
present. A score of 2 was used for congestion occupying less than half of both 
lungs. A score of 3 was used for diffuse congestion occupying over half of both 
lung fields. A score of 4 was used when complete opacification of both lungs was 
present. Grades 3 and 4 were considered “white lungs”. The presence of white 
lungs was examined as a categorical variable. The grade of congestion was 
examined as a continuous variable. Ordinal logistic regression was used for the 
analysis. 
Results 
The sample size analyzed included 46 events of VA ECMO support in 44 
individual patients. In 34 (73.9%) patients the lungs became opacified and 
reached a score of 3 or 4 (the white lungs group), while in 12 (%) patients there 
were no white lungs. 
Overall, the percentage of patients that survived to weaning off VA ECMO was 
60.9%. The percentage of patients that survived to hospital discharge was 
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37.0%. In patients who did not have white lungs the percentages of survival to 
weaning off VA ECMO and survival to hospital discharge were 91.7% and 66.7%, 
respectively. In those with white lungs, the percentages of survival to weaning off 
VA ECMO and survival to hospital discharge were 50.0% and 26.5%, 
respectively (p=0.019 for discharged alive). 
The duration of VA ECMO support, ECMO flow, daily fluid balance, sum net fluid 
balance for the length of stay, and use of hemodialysis predicted a higher degree 
of pulmonary congestion. 
Conclusion 
Severe pulmonary congestion, or white lungs, is common in patients on VA 
ECMO and is associated with very poor prognosis. Longer duration of support, 
greater positive fluid balance, higher ECMO flow, and use of hemodialysis are 
linked to development of white lungs. 
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Abbreviations 
 
Alb               Albumin 
AMI             Acute myocardial infarction 
CI                Confidence intervals 
CPR            Cardiopulmonary resuscitation 
CXR            Chest radiograph 
HD               Hemodialysis 
HF               Heart failure 
LOS             Length of stay 
PE                Pulmonary embolism 
RVF             Right ventricular failure 
VA ECMO   Veno-arterial extracorporeal membrane oxygenation therapy   
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Introduction 
Veno-arterial extracorporeal membrane oxygenation therapy (VA ECMO) is used 
for short-term circulatory support in the setting of cardiogenic shock or cardiac 
arrest. While VA ECMO improves hemodynamics and gas exchange, it may 
result in left ventricular distention and pulmonary congestion. Creating a 
retrograde aortic flow, ECMO can increase left ventricular end diastolic pressure 
and therefore precipitate left ventricular failure, manifesting as pulmonary 
congestion/edema. 
 The phenomenon analyzed in this paper is referred to as “ECMO lungs” or “left 
ventricular distension”.  In this manuscript it is referred to as “white lungs” to 
reflect the extreme opacification of both lung fields to the degree that would be 
incompatible with life if gas exchange was not provided by the oxygenator. The 
prevalence of this condition, effects on survival, and factors associated with its 
development are largely unknown in the adult population treated for cardiogenic 
shock. 
Methods 
The records of all patients supported with VA ECMO for at least 3 consecutive 
days at The University of Kentucky Medical Center from 2012- 2014 were 
retrospectively analyzed. Each patient was supported by VA ECMO and had a 
daily chest radiograph (CXR).  Data measuring central venous pressure, systolic, 
diastolic, and mean arterial pressure, daily fluid balance, and the net fluid 
balance while supported with VA ECMO were collected. 
The daily CXR for each patient supported with VA ECMO was reviewed. All 
patients with gross pre-existing lung pathology such as diffuse fibrosis or 
conditions involving only one lung such as pneumothorax, hemithorax, bronchial 
occlusion, etc. were excluded from this analysis.  Based on the degree of lung 
opacification, all CXRs were graded on a scale of 1 to 4. A score of 1 was used 
when no pulmonary congestion was present.  A score of 2 was used for 
congestion occupying less than half of both lungs.  A score of 3 was used for 
diffuse congestion occupying over half of both lung fields.  A score of 4 was used 
when complete opacification of both lungs was present. (Figures 1-4). The 
scoring was done initially by two cardiologists and then independently by the 
radiologist who was blinded to clinical information. 
If an individual patient had more than half of the lung fields opacified (score of 3 
or 4) at any time while being supported by VA ECMO they were included into the 
white lungs group.  
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Figure 1. Grade 1  
 
 
 
Figure 2. Grade 2 
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Figure 3. Grade 3 
 
 
Figure 4. Grade 4 
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All patients were grouped into the following categories based on their indication 
for use of VA ECMO support: cardiac arrest, acute myocardial infarction, heart 
failure (HF), right ventricular failure not secondary to acute pulmonary embolism, 
acute pulmonary embolism, and postcardiotomy syndrome. All cases where VA 
ECMO support was initiated during cardiopulmonary resuscitation (CPR) or 
immediately following restoration of spontaneous circulation following CPR were 
classified as cardiac arrest regardless of the underlying etiology of cardiac arrest.  
Presence of white lungs was examined as a binary variable, and grade of 
congestion as an ordinal variable. Wilcoxon rank sum test and Fisher’s exact test 
were used to compare groups of persons on numeric and binary variables 
respectively; Spearman’s correlation was used to assess association between 
two numeric variables (or one numeric and one ordinal variable). Ordinal logistic 
models were used to relate several factors to maximal and day-specific 
measurements of congestion; to clarify the terminology by an example, a person 
with three consecutive day-specific measurements of 2, 2, and 3 would have a 
maximal measurement of 3 (and an average measurement of 2.33). Version 9.3 
of SAS was used to analyze data, and statistical significance was defined by a p-
value < 0.05. 
Results 
106 events of VA ECMO support occurred during the time of this analysis. 
Events were excluded from this analysis if the patient was supported with VA 
ECMO for less than three days (46 events). Also, 14 events where the patients 
had focal pulmonary abnormalities on pre-ECMO CXR (hemithorax, main 
bronchus occlusion, idiopathic pulmonary fibrosis, etc.) were excluded. The final 
dataset consisted of 46 events in 44 patients. The mean age was 51.6 ±16.5 
years, and 31.8% of the patients analyzed were females.  Central cannulation 
was used in 14 cases (30.4%).  Cannulae were placed in femoral vein/femoral 
artery in all other cases.  
Other pertinent characteristics were left ventricular ejection fraction (mean 
26.1±17.6%) and pulmonary capillary wedge pressure (23.9±11.5 mmHg)_ 
In 34 (73.9%) patients, lungs became opacified and reached score of 3 or 4 (the 
white lungs group) while in 12(%) patients there were no white lungs. 
Overall, the percentage of patients that survived to weaning off VA ECMO was 
60.9%.  The percentage of patients that survived to hospital discharge was 
37.0%. In patients who did not have white lungs the percentages of survival to 
weaning off VA ECMO and survival to hospital discharge were  91.7% and 
66.7%, respectively.  In those with white lungs, the percentages of survival to 
weaning off VA ECMO and survival to hospital discharge were 50.0% and 26.5%, 
respectively (p=0.019 for discharged alive). 
Referring to the categories created to indicate the etiology of cardiogenic shock, 
patients developed white lungs in each group, and this phenomenon was 
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associated with poor survival (Table 1). Although the sample size is limited, there 
was a trend for patients supported with VA ECMO due to cardiac arrest, 
postcardiotomy syndrome, and HF to develop white lungs more frequently than in 
other conditions. Duration of support was longer for patients with white lungs. 
Table 1.  Survival to weaning off ECMO and to discharge depending on the 
presence of white lungs.   
 
 N % Survived 
on  
ECMO 
% Survi-
ved to 
dis-
charge 
% LOS Duration 
of 
support 
HD % Alb % 
Total 46  28 60.9 17 37.0 28 [12-60] 6 [4-11] 17 37.8 18 40.0 
White lungs 34 73.9 17 50.0 9 26.5 23.5 [10-55] 6.5 [4-12] 16 47.1 16 48.5 
No white 
lungs 
12 26.1 11 91.7* 8 66.7* 33.5 [22-
69.5] 
4 [3-6]* 1 9.1* 2 16.7 
Cardiac 
arrest 
14  7 50.0 4 28.6 26 [10-74] 6 [4-7] 5 38.5 6 42.9 
White lungs 11 78.6 4 36.4 1 9.1 18 [5-55] 7 [4-9] 4 36.4 6 54.5 
No white 
lungs 
3 21.4 3 100 3 100* 92 [28-121] 4 [3-6] 1 50.0 0 0.0 
Acute 
myocardial 
infarction 
6  5 83.3 2 33.3 24 [11-29] 5 [4-6] 2 33.3 2 33.3 
White lungs 3 50.0 2 66.7 1 33.3 20 [3-29] 4 [3-6] 2 66.7 1 33.3 
No white 
lungs 
3 50.0 3 100 1 33.3 28 [11-64] 6 [4-8] 0 0.0 1 33.3 
Heart 
Failure 
16  11 68.8 8 50.0 23.5 [16-
86.5] 
5.5 [4-12] 5 31.3 5 33.3 
White lungs 13 81.3 8 61.5 6 46.2 23 [16-98] 11 [5-12] 5 38.5 5 41.7 
No white 
lungs 
3 18.7 3 100 2 66.7 35 [16-75] 4 [3-5] 0 0.0 0  0.0 
Pulmonary 
embolism 
1  1 100 1 100 32 [na] 3 [na] 0 0.0 0 0.0 
White lungs 0 0.0 0 na 0 na na na 0 na 0 na 
No white 
lungs 
1 100 1 100 1 100 32 [na] 3 [na]  0 0.0 0  0.0 
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Right 
Ventricular 
Failure 
3  3 100 2 66.7 57 [45-68] 16 [6-32] 2 66.7 2 66.7 
White lungs 2 66.7 2 100 1 50.0 56.5 [45-68] 24 [16-
32] 
1 50.0 1 50.0 
No white 
lungs 
1 33.3 1 100 1 100 57 [na] 6 [na] 1 100 1 100 
Postcardio-
tomy 
syndrome 
5  1 20.0 0 0.0 14 [12-51] 4 [3-5] 3 60.0 3 60.0 
White lungs 4 80.0 1 25.0 0 0.0 32.5 [10-53] 4.5 [3.5-
9.5] 
3 75.0 2 50.0 
No white 
lungs 
1 20.0 0 0.0 0 0.0 12 [na] 3 [na] 0 0.0 1 100 
 
* indicates P < 0.05 versus comparable subgroup with white lungs using 
Wilcoxon rank sum test (LOS and duration of support; Median and interquartile 
range also shown) and Fisher’s exact test (Survived on ECMO, Survived to 
discharge, HD, and Alb).  Note, one person had a missing value on HD, and one 
person had a missing value on Alb; percentages are calculated accordingly. 
Duration of ECMO support, ECMO flow, daily fluid balance, sum net fluid balance 
for the length of stay, and being on hemodialysis predicted higher degree of 
pulmonary congestion (Table 2.) Systolic, diastolic, pulse, or mean systemic 
pressure, or mean central venous pressure were not predictors of white lungs or 
higher CXR score. Left ventricular ejection fraction by echo and pulmonary 
capillary wedge pressure by Swan-Ganz catheter was not associated with the 
severity of pulmonary congestion. 
Mechanical ventilatory support was used (synchronized intermitted mandatory 
ventilation) in 36 (78.3%) cases. The mean tidal volume was 483±83.7 mL, mean 
peep pressure was 6.1±1.2 mmHg, mean respiratory rate was 13.5± 3.1 per 
minute, and mean FiO2 was 48.5±7%. There was no difference between the 
white lung group and no white lung group by any of the parameters. 
Systolic, diastolic, pulse, and mean arterial pressure, as well as central venous 
pressure were not significant predictors of maximal CXR score; among several 
factors examined, only albumin use was (estimated unadjusted odds ratio 3.382, 
95% CI 1.027 to 11.131, p-value = 0.0450). 
In 34 patients with white lungs, 14 had severe pulmonary opacification prior to 
the initiation of VA ECMO. Only 3 of them improved on support. In 20 patients, 
white lungs developed while on VA ECMO support. In this group, mean time to 
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the development of white lungs was 5.0+/-3.8 days. 10 of them improved while 
on VA ECMO support. 
Table 2. Factors predicting white lungs on VA ECMO 
 Predictor Estimate of 
odds ratio 
Lower limit of 
95% CI 
Upper limit of 
95% CI 
p-value 
Time (days on 
ECMO) 1.236 1.185 1.289 
<.0001 
Net daily 
balance 1.107 1.028 1.193 
0.0077 
Sum net 
balance 1.130 1.093 1.167 
<.0001 
ECMO Flow 1.845 1.316 2.587 0.0004 
Ventilator 0.704 0.302 1.643 0.4175 
Hemodialysis 2.875 1.125 7.350 0.0282 
Mean arterial 
pressure 
0.983 0.967 1.000 0.0524 
Results are based on ordinal logistic mixed models.  Each odds ratio estimate is not 
adjusted for the other variables considered.  By virtue of the ordinal logistic modeling, the 
odds ratios pertain simultaneously to dichotomizations of “4 vs. 3 or lower”, “3 or higher 
vs. 2 or lower”, and “2 or higher vs. 1”. CI = confidence interval. 
In the majority of patients, pulmonary opacification became worse on ECMO 
support comparing with the baseline (before the ECMO placement). In only 10 
cases, there was no deterioration of pulmonary status. In the other 36, lungs 
became worse on ECMO support, even if the status did not progress to white 
lungs, and opacification occupied less than half of lung fields.  Table 3 shows the 
numbers and percentages of cases with deterioration, by indication. 
In 13  patients, there was decompression of the left ventricle by means of an 
alternative form of mechanical circulatory support. In eight cases, intraaortic 
balloon pump was used. Four patients were also on long-term left ventricular 
assist device (Heartmate II), and one had an Impella 2.5. Because many of the 
devices were used only for a part of the time on VA ECMO, it would be difficult to 
derive any conclusions regarding their role in pulmonary congestion. 
Specifically, out of 8 cases where intraaortic balloon pump was used, three 
patients never developed white lungs, but only one of them survived to 
discharge. Out of those five who had white lungs, only two improved, and one of 
them survived. Heartmate II was not implanted to decompress the left ventricle, it 
was already present when patients went on ECMO. None of them survived. 
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Table 3.  Deterioration of pulmonary status on ECMO support, by indication 
Indication Number with 
indication 
Number with 
deterioration 
Percentage with 
deterioration 
Cardiac arrest 14 9 64.3% 
Acute myocardial 
infarction 
6 4 66.7% 
Heart failure 16 15 93.8% 
Pulmonary 
embolism 
1 1 100% 
Right ventricular 
failure 
3 3 100% 
Postcardiotomy 
syndrome 
5 3 60.0% 
The indication for one person was “other”.  This person did get worse. 
Finally, Table 4 presents p-values for tests of whether the indicated variables are 
associated with each other.  Each measurement of congestion is significantly 
related to four out of the five outcome or treatment variables. 
Table 4. Relationships of congestion measurements to outcomes and 
treatments 
 Duration of 
support 
Survival to 
ECMO 
Survival to 
discharge 
Albumin Hemodialysis 
Average 
CXR score 
p=0.117 p=0.011 p=0.030 p=0.001 p=0.013 
Maximal 
CXR score 
p=0.012 p=0.014 p=0.214 p=0.012 p=0.047 
White 
lungs 
p=0.015 p=0.015 p=0.019 p=0.086 p=0.033 
All outcomes and treatments are significantly related to at least two out of the 
three measurements of congestion. 
Discussion 
In our experience, severe degree of pulmonary congestion, with opacification of 
greater than half of both lung fields is a frequent complication of VA ECMO in 
adult patients. Specifically, in patients supported on VA ECMO for three days or 
more, white lungs were present in almost 74% of the cases. This complication 
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was associated with very high mortality – only 26.5% were discharged alive 
compared to 66.7% in patients without white lungs. 
Longer time of support with VA ECMO, higher ECMO flow, and net fluid balance 
(both daily and for the duration of VA ECMO support) were associated with 
higher degree of congestion. Historically, VA ECMO was widely used in the 
pediatric population. Relatively recently, it has become a commonly used 
modality for extracorporeal life support in adults in the setting of cardiogenic 
shock. 
Pulmonary congestion is rarely described in ECMO-related literature. The closest 
term is “left ventricular distension” and there is no uniform way of describing this 
phenomenon. Some authors suggest that it is diagnosed by echocardiography 
(1).  By default, prevalence and effects of this condition are different than 
pulmonary congestion diagnosed by CXR. The incidence of left ventricular 
distension varies widely, ranging from 12-68% (1). However, a review of VA 
ECMO literature revealed no reports regarding the prevalence of severe 
pulmonary congestion. In our cohort, the percentage of patients with severe 
pulmonary congestion was 73.9%. However, only patients supported with VA 
ECMO for at least three consecutive days were included in this analysis, which 
likely resulted in a higher incidence of severe pulmonary congestion than that of 
all patients supported with VA ECMO. As we found, duration of support is directly 
related to severity of pulmonary congestion. Recently, positive fluid balance while 
on ECMO support was reported to be an independent predictor of hospital and 
90-day mortality (2). 
Extreme degree of pulmonary congestion, which we referred to as white lungs, is 
inconsistently reported. In the US ECLS registry (https://www.elso.org/Registry), 
this complication is not listed, and therefore is not systematically reported and 
analyzed.  Pulmonary hemorrhage, which is listed as a complication in the 
registry, probably overlaps with the phenomenon we refer to as white lungs, but 
is a distinct and different clinical entity. 
Meanwhile, we found that white lungs is a common and serious complication, 
and is associated with high mortality. Per our data, patients who do not 
experience critical pulmonary opacification survive to discharge in 66.7% cases; 
survival is only 26.5% in patients who develop white lungs. 
There are several potential mechanisms contributing to development of white 
lungs, which include but are not limited to the following: 
 
 Increased left ventricular end-diastolic pressure due to retrograde 
ECMO flow into the ascending aorta in central cannulation or 
femoral artery in peripheral cannulation 
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 Increased left ventricular afterload due to increased systemic 
pressure (considering that prior to VA ECMO initiation, patients 
were in cardiogenic shock with low systemic pressure) 
 High pulmonary venous return to the left atrium due to intrinsically 
high collateral flow from the bronchial circulation to the pulmonary 
circulation (1) 
 The failure of the aortic valve to open due to either the severity of 
LV impairment or the presence of excessively high systemic 
vascular resistance imposing a high afterload (1)  
 Aortic insufficiency (1) 
 High ECMO flow (3) 
 
Interestingly, in an animal model in which five pigs were supported with different 
rates of ECMO flow ranging from 1 to 5 L/min, increased flow resulted in 
decreased cardiac output. Cardiac output decreased form 2.8 +/- 0.3 L/min to 
1.86 +/- 0.53 L/min (P < 0.001) and left ventricular ejection fraction decreased 
from 43 +/- 3 % to 32 +/- 3 % (P < 0.001). LV end-systolic volume also increased. 
Surprisingly, left ventricular end-diastolic pressure and volume were not 
significantly affected.(4)  
At our institution, we did not consistently use any particular strategy to 
decompress the left ventricle. Anecdotally, we used hemofiltration, diuretic drips, 
Impella, and intraaortic balloon pump. Several patients were on left ventricular 
support at the same time. However, each of the methods was used in very few 
cases, and no statistical analysis could be justified. 
In the literature, various strategies of left ventricular decompression have been 
proposed:   
 Intravenous diuresis. We were anecdotally successful with 
furosemide drip at 2.5 mg/hour An attempt to use a higher dose 
led to line chattering and instability of the ECMO circuit.  
 Ultrafiltration via the ECMO circuit or via separate access (1) 
 Intraaortic ballon pump (1) 
 Percutaneous blade or balloon septostomy (5) 
 Pigtail catheter, introduced in the left ventricle through the aortic 
valve, connected to the venous drainage inserted in the femoral 
artery contralateral to the arterial cannula (6) 
 Impella (7, 8) 
 
Other options regarding surgical or percutaneous decompression of the left 
ventricle are discussed in detail in a review by Rupprecht et al.(3). Left ventricular 
decompression for the treatment of refractory cardiogenic shock and lung failure 
brings high success rate and should be utilized early in the care of patients on 
VA ECMO (9). 
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Limitations 
Our study is limited by retrospective nature of the analysis. Data were recorded 
in the charts for clinical needs, and some variables had missing values. Also, 
because we were interested in the phenomenon of severe pulmonary 
congestion, we intentionally limited the patient population to those who were on 
support for at least three consecutive days, and therefore increased the 
representation of this phenomenon. 
The groups with white lungs and no white lungs were very uneven, and this could 
result in no statistically significant differences in some parameters. 
Conclusions 
Severe pulmonary congestion or white lungs is common in patients on VA ECMO 
and is associated with a very poor prognosis. Longer duration of support, greater 
positive fluid balance, higher ECMO flow, and use of hemodialysis are linked to 
development of white lungs. 
Institutions using VA ECMO in adult patients should pay particular attention to 
the prevention and treatment of white lungs. Measures taken to prevent or treat 
white lungs can include but are not limited to maintenance of a net negative fluid 
balance, use of lower ECMO flows, and mechanical decompression of the left 
ventricle.  
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